A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: A future drug against a fatal neoplastic disease?

Marco Tomasetti, Nina Gellert, Antonio Procopio, Jiri Neuzil

Research output: Contribution to journalArticle

Abstract

Malignant mesothelioma is a fatal type of neoplasia of the pleura and the peritoneum with currently no known cure. Therefore, discovery of an efficient antimesothelioma drug with low deleterious side effects is desirable. Here, we studied in vivo the effect of α-tocopheryl succinate, a semisynthetic vitamin E analogue with proapoptotic and anticancer activity and selectivity for malignant cells, on experimental peritoneal mesothelioma using immunocompromised mice. Compared to untreated animals, the agent increased their survival >3-fold. Our finding warrants further testing of vitamin E analogues as potential antimesothelioma drugs.

Original languageEnglish
Pages (from-to)641-642
Number of pages2
JournalInternational Journal of Cancer
Volume109
Issue number5
DOIs
Publication statusPublished - May 1 2004

Keywords

  • α-tocopheryl succinate
  • Mesothelioma
  • Preclinical model
  • Selective effect
  • Vitamin E analogue

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: A future drug against a fatal neoplastic disease?'. Together they form a unique fingerprint.

  • Cite this